Nuvation Bio Inc. (NYSE:NUVB) Q3 2025 Earnings Call Transcript November 3, 2025
Nuvation Bio Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.17.
Operator: Hello, and welcome to Nuvation Bio’s Third Quarter 2025 Financial Results and Corporate Update Call. Today’s call is being recorded, and a replay will be available. [Operator Instructions] Now I’d like to turn the call over to JR DeVita, Executive Director of Corporate Development and Investor Relations at...
